Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+153.1%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+153.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
16.2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$512.43M+62.7%
2024$314.93M+102.6%
2023$155.42M+391.8%
2022$31.60M-